Breaking barriers-Suppressing revolt
While immunity is intrinsically designed to protect the self against foreign antigens, in the era of transplantation – allograft or xenograft, whole organ or stem cells – a deliberate attempt is made to suppress immune pathways that would reject the transplant. The barrier to tolerating the graft is broken by suppressing the expected revolt by cellular and humoral immunity, enabling successful survival and functional engraftment. The rare possibility of the donor being a twin of course obviates the possibility of rejection. To begin with blood group and HLA cross-matching reduce the possibility of graft survival by minimizing key donor antigens that the donor or recipient APCs will present to the T-cells to. In contemporary practice, renal transplantation is most frequent and well established, followed by liver, heart, pancreas and others. Iatrogenic immunosuppression with a host of drugs targeting immune pathways, has a cost: a lifelong follow-up to monitor rejection- hyperacute, acute and chronic; usual and unusual opportunistic infections with morbid and mortal outcomes and, appearance of neoplasia of certain types unique to the transplantation setting, often triggered by activation of oncogenic viruses. A full account of these can be found in standard textbooks and review articles: some suggestions are placed at the end of this post.
(more…)